Итак, все приведенные Вами материалы, Дарина, свидетельствуют об одном - все на экспериментальном уровне. Рибавирин и Сидофовир скорее обладают более тяжкими побочками, нежели лечебным эффектом. Упомянутый интерферон, во первых отличается от "офтальмоферона" но и опять же нет информации, доказательств эффективности.
Я не думаю, что ставить эксперименты над людьми это этично, или просто хорошо.
Ваш клинический опыт, равно как и мой, отдельно взятые не могут рассматриваться в качестве каких либо доказательств. Это "пиццот" раз обсуждалось в стенах РМС.
Давайте обратимся к руководствам:
[
Ссылки доступны только зарегистрированным пользователям ]
Цитата:
Adenoviral Conjunctivitis
Patients with adenoviral conjunctivitis should be informed of appropriate measures to reduce the risk that they may spread the infection to their other eye or to other people.[B:III] There is no effective treatment for adenovirus infection; however, artificial tears, topical antihistamines, or cold compresses may be used to mitigate symptoms.
Topical steroids are helpful to reduce scarring in severe cases of adenoviral keratoconjunctivitis with marked chemosis or lid swelling, epithelial sloughing, or membranous conjunctivitis. In an animal model of adenoviral conjunctivitis, administration of topical corticosteroid lead to prolonged viral shedding. Patients who use topical corticosteroid should be instructed to maintain precautions against the spread of the virus for 2 additional weeks after symptoms resolve.[A:III] For patients with membranous conjunctivitis, debridement of the membrane may enhance the efficacy of corticosteroid therapy and improve comfort.
Patients with severe disease who have corneal epithelial ulceration or membranous conjunctivitis should be re-evaluated within 1 week.[A:III] The follow-up visit should include an interval history, measurement of visual acuity, and slit-lamp biomicroscopy.[A:III]
Other patients should be instructed to return for follow-up if they continue to experience symptoms of red eye, pain, or decreased vision after 2 to 3 weeks.[A:III] This follow-up visit should include an interval history, measurement of visual acuity, and slit-lamp biomicroscopy.[A:III]
Patients treated with topical corticosteroids for irritation or visual symptoms due to subepithelial infiltrates or late onset epithelial granularity should have the dosage slowly tapered to the minimum effective dose.[A:III]
Corticosteroids with poor ocular penetration, such as fluorometholone, or site specific steroids, such as rimexolone, may be less likely to result in elevated intraocular pressure or cataract formation. Follow-up examination should occur every 4 to 8 weeks, and visits should include an interval history, measurement of visual acuity and intraocular pressure, and slit-lamp biomicroscopy.[A:III] Recurrence of subepithelial infiltrates has been reported in patients with a history of adenoviral infection who have undergone photorefractive keratectomy or laser in situ keratomileusis.51,52
|
[Ссылки доступны только зарегистрированным пользователям ]
Здесь можно найти руководства по многим нозологиям глазных болезней.
П.С. Сорри, привел отдельные статьи на английском, без перевода, так как идет обсуждение врачебного аспекта, не для пациента.